PPARγ activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction
Study Overview The research focuses on the therapeutic effects of leriglitazone, a PPARγ (peroxisome proliferator-activated receptor gamma) agonist, in a […]
